FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414897890> ?p ?o ?g. }

• W2414897890 endingPage "110" @default.
• W2414897890 startingPage "104" @default.
• W2414897890 abstract "The comparative efficacy of subcutaneous injections and intranasal spray in the maintenance of suppression of testicular function in men with advanced prostatic cancer treated with a gonadotropin-releasing hormone (GnRH) agonist, Buserelin, was evaluated in a nonrandomized clinical trial. After a common induction period of 1 week’s treatment with 500 µ g three times daily by subcutaneous injection, patients were allocated into one of two groups for maintenance therapy with either subcutaneous (200 µ g once daily) or intranasal (400 µ g nasal spray three times daily) Buserelin therapy. Plasma luteinizing hormone (LH) and sex steroid (testosterone [T], dihydrotestosterone [DHT], and estradiol [E 2 ]) patterns were studied before the start and at days 1, 7, and 14 and months 2, 4, 6, and 12 on maintenance regimens. During the maintenance therapy, age-adjusted T levels were markedly suppressed to near-castrate levels in both treatment groups. Despite this marked suppression, age-adjusted T levels were consistently lower in men treated with the subcutaneous regimen from the 2nd week to the 12th month of treatment in morning pooled specimens as well as in detailed sampling over a 24-hour period after 12 months of continuous treatment. A similar pattern of enhanced suppression by the subcutaneous regimen was also observed for age-adjusted DHT, but not E 2 , levels during the study. Neither the magnitude nor the time course of T suppression by GnRH analog treatment could be entirely explained by the nature of the decline in plasma LH levels, which fell much less and more gradually over a 12-month period. These results suggest the two maintenance regimens are not equivalent and that, in the regimens used, subcutaneous therapy produces more complete androgen suppression, presumably due to the suboptimal intranasal dose regimen, although pharmacokinetic route-dependent limitations cannot be entirely excluded." @default.
• W2414897890 created "2016-06-24" @default.
• W2414897890 creator A5001070920 @default.
• W2414897890 creator A5015887403 @default.
• W2414897890 creator A5023450739 @default.
• W2414897890 creator A5039213409 @default.
• W2414897890 creator A5063708769 @default.
• W2414897890 creator A5090807122 @default.
• W2414897890 date "1986-07-01" @default.
• W2414897890 modified "2023-09-26" @default.
• W2414897890 title "Comparison of the efficacy of subcutaneous and nasal spray Buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer" @default.
• W2414897890 cites W1964383108 @default.
• W2414897890 cites W1972007837 @default.
• W2414897890 cites W1975035830 @default.
• W2414897890 cites W1992601773 @default.
• W2414897890 cites W1997951188 @default.
• W2414897890 cites W2006732320 @default.
• W2414897890 cites W2014200423 @default.
• W2414897890 cites W2014689988 @default.
• W2414897890 cites W2019037346 @default.
• W2414897890 cites W2056059392 @default.
• W2414897890 cites W2059753575 @default.
• W2414897890 cites W2060571369 @default.
• W2414897890 cites W2060991243 @default.
• W2414897890 cites W2074185602 @default.
• W2414897890 cites W2079205186 @default.
• W2414897890 cites W2088987832 @default.
• W2414897890 cites W2094406136 @default.
• W2414897890 cites W2410599495 @default.
• W2414897890 cites W2416878667 @default.
• W2414897890 cites W4253882649 @default.
• W2414897890 cites W4296792766 @default.
• W2414897890 doi "https://doi.org/10.1016/s0015-0282(16)49466-5" @default.
• W2414897890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3087785" @default.
• W2414897890 hasPublicationYear "1986" @default.
• W2414897890 type Work @default.
• W2414897890 sameAs 2414897890 @default.
• W2414897890 citedByCount "17" @default.
• W2414897890 countsByYear W24148978902017 @default.
• W2414897890 crossrefType "journal-article" @default.
• W2414897890 hasAuthorship W2414897890A5001070920 @default.
• W2414897890 hasAuthorship W2414897890A5015887403 @default.
• W2414897890 hasAuthorship W2414897890A5023450739 @default.
• W2414897890 hasAuthorship W2414897890A5039213409 @default.
• W2414897890 hasAuthorship W2414897890A5063708769 @default.
• W2414897890 hasAuthorship W2414897890A5090807122 @default.
• W2414897890 hasConcept C121608353 @default.
• W2414897890 hasConcept C126322002 @default.
• W2414897890 hasConcept C126894567 @default.
• W2414897890 hasConcept C134018914 @default.
• W2414897890 hasConcept C170493617 @default.
• W2414897890 hasConcept C203014093 @default.
• W2414897890 hasConcept C2776390293 @default.
• W2414897890 hasConcept C2777230143 @default.
• W2414897890 hasConcept C2777911890 @default.
• W2414897890 hasConcept C2778575703 @default.
• W2414897890 hasConcept C2778938600 @default.
• W2414897890 hasConcept C2779279991 @default.
• W2414897890 hasConcept C2779881493 @default.
• W2414897890 hasConcept C2780192828 @default.
• W2414897890 hasConcept C2780973058 @default.
• W2414897890 hasConcept C2781413609 @default.
• W2414897890 hasConcept C71315377 @default.
• W2414897890 hasConcept C71924100 @default.
• W2414897890 hasConcept C85663871 @default.
• W2414897890 hasConceptScore W2414897890C121608353 @default.
• W2414897890 hasConceptScore W2414897890C126322002 @default.
• W2414897890 hasConceptScore W2414897890C126894567 @default.
• W2414897890 hasConceptScore W2414897890C134018914 @default.
• W2414897890 hasConceptScore W2414897890C170493617 @default.
• W2414897890 hasConceptScore W2414897890C203014093 @default.
• W2414897890 hasConceptScore W2414897890C2776390293 @default.
• W2414897890 hasConceptScore W2414897890C2777230143 @default.
• W2414897890 hasConceptScore W2414897890C2777911890 @default.
• W2414897890 hasConceptScore W2414897890C2778575703 @default.
• W2414897890 hasConceptScore W2414897890C2778938600 @default.
• W2414897890 hasConceptScore W2414897890C2779279991 @default.
• W2414897890 hasConceptScore W2414897890C2779881493 @default.
• W2414897890 hasConceptScore W2414897890C2780192828 @default.
• W2414897890 hasConceptScore W2414897890C2780973058 @default.
• W2414897890 hasConceptScore W2414897890C2781413609 @default.
• W2414897890 hasConceptScore W2414897890C71315377 @default.
• W2414897890 hasConceptScore W2414897890C71924100 @default.
• W2414897890 hasConceptScore W2414897890C85663871 @default.
• W2414897890 hasIssue "1" @default.
• W2414897890 hasLocation W24148978901 @default.
• W2414897890 hasLocation W24148978902 @default.
• W2414897890 hasOpenAccess W2414897890 @default.
• W2414897890 hasPrimaryLocation W24148978901 @default.
• W2414897890 hasRelatedWork W1985841978 @default.
• W2414897890 hasRelatedWork W1991634850 @default.
• W2414897890 hasRelatedWork W2006690885 @default.
• W2414897890 hasRelatedWork W2026882188 @default.
• W2414897890 hasRelatedWork W2027210979 @default.
• W2414897890 hasRelatedWork W2050826448 @default.
• W2414897890 hasRelatedWork W2052998204 @default.
• W2414897890 hasRelatedWork W2071338496 @default.
• W2414897890 hasRelatedWork W2081257388 @default.

• next